CITICOLINE 500mg. IP + PIRACETAM 800mg. IP

A neuroprotective agent that treats acute and chronic brain ischaemic, and neurodegenerative diseases, including brain hypoxia, ischemia, and intracerebral hemorrhage. Reduces central nervous system ischemic injury by stabilizing cell membranes and reducing free radical generation. (W M Clark, 1999) Increases compromised cerebral blood flow in patients with acute stroke. (P P De Deyn, 1997) Demonstrates neuroprotective effects in acute stroke and improves cognition in patients with chronic cerebrovascular disease. (Jose Alvarez-Sabín, 2011) Effectively regenerating neurons increases the levels of neurotransmitters and has a positive impact on cognitive functions. (Patryk Jasielski, 2020) Provides neurovascular protection and repair effects and treats acute ischemic stroke and other neurological disorders. (Julio J. Secades, 2016) A safe and promising alternative to improve stroke recovery. (Jose Alvarez-Sabín, 2011) A safe and effective in improving post-stroke cognitive decline and enhancing patients’ functional recovery. (Román, 2013) A beneficial compound in preventing dementia progression. (Patryk Jasielski, 2020) A potentially beneficial drug against memory loss due to aging. (Eri Nakazaki, 2021)